Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 398

1.

Express: Time-Gated Single-Shot Picosecond Laser-Induced Breakdown Spectroscopy (ps-LIBS) for Equivalence-Ratio Measurements.

Hsu PS, Gragston M, Patnaik AK, Zhang Z, Roy S.

Appl Spectrosc. 2019 Oct 16:3702819885647. doi: 10.1177/0003702819885647. [Epub ahead of print] No abstract available.

PMID:
31617399
2.

Pediatric moyamoya disease presenting as attention deficit hyperactivity disorder: Time to pay attention.

Patra S, Patnaik A.

Indian J Psychiatry. 2019 Sep-Oct;61(5):544-545. doi: 10.4103/psychiatry.IndianJPsychiatry_403_18. No abstract available.

3.

Oxidation State-Dependent Electronic Properties of Sulfur-Containing Thermally Activated Delayed Fluorescence Molecules.

Varathan E, Patnaik A.

J Phys Chem A. 2019 Oct 17;123(41):8755-8765. doi: 10.1021/acs.jpca.9b05923. Epub 2019 Oct 7.

PMID:
31538786
4.

Design of Dual Hybrid Network Natural Rubber-SiO2 Elastomers with Tailored Mechanical and Self-Healing Properties.

Sattar MA, Gangadharan S, Patnaik A.

ACS Omega. 2019 Jun 24;4(6):10939-10949. doi: 10.1021/acsomega.9b01243. eCollection 2019 Jun 30.

5.

Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.

Paller CJ, Antonarakis ES, Beer TM, Borno HT, Carlo MI, George DJ, Graff JN, Gupta S, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Petrylak DP, Rettig MB, Ryan CJ, Taplin ME, Whang YE, Vinson J, Cheng HH, Giri VN; PCCTC Germline Genetics Working Group.

Clin Genitourin Cancer. 2019 Aug;17(4):275-282.e1. doi: 10.1016/j.clgc.2019.04.013. Epub 2019 Apr 18.

PMID:
31171481
6.

Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study.

Garon EB, Hellmann MD, Rizvi NA, Carcereny E, Leighl NB, Ahn MJ, Eder JP, Balmanoukian AS, Aggarwal C, Horn L, Patnaik A, Gubens M, Ramalingam SS, Felip E, Goldman JW, Scalzo C, Jensen E, Kush DA, Hui R.

J Clin Oncol. 2019 Oct 1;37(28):2518-2527. doi: 10.1200/JCO.19.00934. Epub 2019 Jun 2.

7.

Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and H.

Gubens MA, Sequist LV, Stevenson JP, Powell SF, Villaruz LC, Gadgeel SM, Langer CJ, Patnaik A, Borghaei H, Jalal SI, Fiore J, Saraf S, Raftopoulos H, Gandhi L.

Lung Cancer. 2019 Apr;130:59-66. doi: 10.1016/j.lungcan.2018.12.015. Epub 2018 Dec 17.

PMID:
30885353
8.

Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study.

Leighl NB, Hellmann MD, Hui R, Carcereny E, Felip E, Ahn MJ, Eder JP, Balmanoukian AS, Aggarwal C, Horn L, Patnaik A, Gubens M, Ramalingam SS, Lubiniecki GM, Zhang J, Piperdi B, Garon EB.

Lancet Respir Med. 2019 Apr;7(4):347-357. doi: 10.1016/S2213-2600(18)30500-9. Epub 2019 Mar 12.

PMID:
30876831
9.

Microsurgical treatment of interhemispheric epidermoid: An institutional series.

Bansal S, Sahu RN, Patnaik A.

Neurol India. 2019 Jan-Feb;67(1):278-281. doi: 10.4103/0028-3886.253650. No abstract available.

10.

Natural rubber-SiO2 nanohybrids: interface structures and dynamics.

Sattar MA, Nair AS, Xavier PJ, Patnaik A.

Soft Matter. 2019 Apr 7;15(13):2826-2837. doi: 10.1039/c9sm00254e. Epub 2019 Feb 28.

PMID:
30816894
11.

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.

Sikic BI, Lakhani N, Patnaik A, Shah SA, Chandana SR, Rasco D, Colevas AD, O'Rourke T, Narayanan S, Papadopoulos K, Fisher GA, Villalobos V, Prohaska SS, Howard M, Beeram M, Chao MP, Agoram B, Chen JY, Huang J, Axt M, Liu J, Volkmer JP, Majeti R, Weissman IL, Takimoto CH, Supan D, Wakelee HA, Aoki R, Pegram MD, Padda SK.

J Clin Oncol. 2019 Apr 20;37(12):946-953. doi: 10.1200/JCO.18.02018. Epub 2019 Feb 27.

PMID:
30811285
12.

Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.

Carlo MI, Giri VN, Paller CJ, Abida W, Alumkal JJ, Beer TM, Beltran H, George DJ, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Ryan CJ, Schaeffer EM, Stadler WM, Taplin ME, Kauff ND, Vinson J, Antonarakis ES, Cheng HH.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00060. Epub 2018 Aug 16.

13.

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.

Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, Wolchok JD, Hersey P, Joseph R, Weber JS, Dronca R, Mitchell TC, Patnaik A, Zarour HM, Joshua AM, Zhao Q, Jensen E, Ahsan S, Ibrahim N, Ribas A.

Ann Oncol. 2019 Apr 1;30(4):582-588. doi: 10.1093/annonc/mdz011.

14.

Effect of Surface Ligand and Temperature on Lipid Vesicle-Gold Nanoparticle Interaction: A Spectroscopic Investigation.

Kanwa N, Patnaik A, De SK, Ahamed M, Chakraborty A.

Langmuir. 2019 Jan 29;35(4):1008-1020. doi: 10.1021/acs.langmuir.8b03673. Epub 2019 Jan 18.

PMID:
30601000
15.

A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors.

Smith DC, Chugh R, Patnaik A, Papadopoulos KP, Wang M, Kapoun AM, Xu L, Dupont J, Stagg RJ, Tolcher A.

Invest New Drugs. 2019 Aug;37(4):722-730. doi: 10.1007/s10637-018-0714-6. Epub 2018 Dec 28.

16.

Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation.

Yang JC, Gadgeel SM, Sequist LV, Wu CL, Papadimitrakopoulou VA, Su WC, Fiore J, Saraf S, Raftopoulos H, Patnaik A.

J Thorac Oncol. 2019 Mar;14(3):553-559. doi: 10.1016/j.jtho.2018.11.028. Epub 2018 Dec 4.

PMID:
30529597
17.

Utilizing precision medicine to modulate the prostate tumor microenvironment and enhance immunotherapy.

Olson B, Patnaik A.

Urol Oncol. 2019 Aug;37(8):535-542. doi: 10.1016/j.urolonc.2018.11.009. Epub 2018 Nov 29. Review.

PMID:
30503851
18.

Correction: Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab.

Joseph RW, Elassaiss-Schaap J, Kefford R, Hwu WJ, Wolchok JD, Joshua AM, Ribas A, Hodi FS, Hamid O, Robert C, Daud A, Dronca R, Hersey P, Weber JS, Patnaik A, de Alwis DP, Perrone A, Zhang J, Kang SP, Ebbinghaus S, Anderson KM, Gangadhar TC.

Clin Cancer Res. 2018 Dec 1;24(23):6098. doi: 10.1158/1078-0432.CCR-18-3340. No abstract available.

PMID:
30510087
19.

Simultaneous LIBS signal and plasma density measurement for quantitative insight into signal instability at elevated pressure.

Patnaik AK, Wu Y, Hsu PS, Gragston M, Zhang Z, Gord JR, Roy S.

Opt Express. 2018 Oct 1;26(20):25750-25760. doi: 10.1364/OE.26.025750.

PMID:
30469671
20.

Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study.

Gadgeel SM, Stevenson JP, Langer CJ, Gandhi L, Borghaei H, Patnaik A, Villaruz LC, Gubens M, Hauke R, Yang JC, Sequist LV, Bachman R, Saraf S, Raftopoulos H, Papadimitrakopoulou V.

Lung Cancer. 2018 Nov;125:273-281. doi: 10.1016/j.lungcan.2018.08.019. Epub 2018 Aug 25.

PMID:
30429032
21.

Mouse Models for Cancer Immunotherapy Research.

Olson B, Li Y, Lin Y, Liu ET, Patnaik A.

Cancer Discov. 2018 Nov;8(11):1358-1365. doi: 10.1158/2159-8290.CD-18-0044. Epub 2018 Oct 11. Review.

22.

Rare case of meningeal tuberculoma mimicking meningioma in term pregnancy and its management.

Singh S, Patnaik A, Sahu RN, Jena SS, Mohakud S, Purkait S.

Surg Neurol Int. 2018 Sep 3;9:178. doi: 10.4103/sni.sni_271_17. eCollection 2018. No abstract available.

23.

24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer.

Borghaei H, Langer CJ, Gadgeel S, Papadimitrakopoulou VA, Patnaik A, Powell SF, Gentzler RD, Martins RG, Stevenson JP, Jalal SI, Panwalkar A, Yang JC, Gubens M, Sequist LV, Awad MM, Fiore J, Saraf S, Keller SM, Gandhi L.

J Thorac Oncol. 2019 Jan;14(1):124-129. doi: 10.1016/j.jtho.2018.08.004. Epub 2018 Aug 21.

PMID:
30138764
24.

Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: a phase 1 dose-escalation trial.

Papadopoulos KP, Ben-Ami E, Patnaik A, Trone D, Li J, Demetri GD.

BMC Cancer. 2018 Aug 6;18(1):790. doi: 10.1186/s12885-018-4692-z.

25.

Discovery of 1-((6-Aminopyridin-3-yl)Methyl)-3-(4-Bromophenyl)Urea as a Potent, Irreversible Myeloperoxidase Inhibitor.

Marro ML, Patterson AW, Lee L, Deng L, Reynolds A, Ren X, Axford L, Patnaik A, Hollis-Symynkywicz M, Casson N, Custeau D, Ames L, Loi S, Zhang L, Honda T, Blank J, Harrison TJ, Papillon JPN, Hamann LG, Marcinkeviciene J, Regard JB.

J Pharmacol Exp Ther. 2018 Oct;367(1):147-154. doi: 10.1124/jpet.118.248435. Epub 2018 Aug 3.

PMID:
30076263
26.

Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer.

Patnaik A, Gordon M, Tsai F, Papadopoulos KP, Rasco D, Beeram M, Fu S, Janku F, Hynes SM, Gundala SR, Willard MD, Zhang W, Lin AB, Hong D.

Cancer Chemother Pharmacol. 2018 Sep;82(3):419. doi: 10.1007/s00280-018-3641-5.

PMID:
30014222
27.

A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer.

Patnaik A, Gordon M, Tsai F, Papadopoulos KP, Rasco D, Beeram M, Fu S, Janku F, Hynes SM, Gundala SR, Willard MD, Zhang W, Lin AB, Hong D.

Cancer Chemother Pharmacol. 2018 Sep;82(3):407-418. doi: 10.1007/s00280-018-3623-7. Epub 2018 Jun 20. Erratum in: Cancer Chemother Pharmacol. 2018 Jul 16;:. Papadopoulous, Kyri [corrected to Papadopoulos, Kyriakos P] and Beeram, S Muralidhar [corrected to Beeram, Muralidhar].

28.

Carbon Nanosheets by Morphology-Retained Carbonization of Two-Dimensional Assembled Anisotropic Carbon Nanorings.

Mori T, Tanaka H, Dalui A, Mitoma N, Suzuki K, Matsumoto M, Aggarwal N, Patnaik A, Acharya S, Shrestha LK, Sakamoto H, Itami K, Ariga K.

Angew Chem Int Ed Engl. 2018 Jul 26;57(31):9679-9683. doi: 10.1002/anie.201803859. Epub 2018 Jul 5.

PMID:
29917300
29.

Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer.

Finn RS, Ahn DH, Javle MM, Tan BR Jr, Weekes CD, Bendell JC, Patnaik A, Khan GN, Laheru D, Chavira R, Christy-Bittel J, Barrett E, Sawyer MB, Bekaii-Saab TS.

Invest New Drugs. 2018 Dec;36(6):1037-1043. doi: 10.1007/s10637-018-0600-2. Epub 2018 May 22.

PMID:
29785570
30.

A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors.

Ferrarotto R, Eckhardt G, Patnaik A, LoRusso P, Faoro L, Heymach JV, Kapoun AM, Xu L, Munster P.

Ann Oncol. 2018 Jul 1;29(7):1561-1568. doi: 10.1093/annonc/mdy171.

PMID:
29726923
31.

Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab.

Joseph RW, Elassaiss-Schaap J, Kefford R, Hwu WJ, Wolchok JD, Joshua AM, Ribas A, Hodi FS, Hamid O, Robert C, Daud A, Dronca R, Hersey P, Weber JS, Patnaik A, de Alwis DP, Perrone A, Zhang J, Kang SP, Ebbinghaus S, Anderson KM, Gangadhar TC.

Clin Cancer Res. 2018 Oct 15;24(20):4960-4967. doi: 10.1158/1078-0432.CCR-17-2386. Epub 2018 Apr 23. Erratum in: Clin Cancer Res. 2018 Dec 1;24(23):6098.

32.

A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers.

Tolcher A, Flaherty K, Shapiro GI, Berlin J, Witzig T, Habermann T, Bullock A, Rock E, Elekes A, Lin C, Kostic D, Ohi N, Rasco D, Papadopoulos KP, Patnaik A, Smith L, Cote GM.

Oncologist. 2018 Jun;23(6):658-e72. doi: 10.1634/theoncologist.2017-0325. Epub 2018 Mar 6.

33.

Nondystrophic holocord intramedullary lipoma: an uncommon case.

Bansal S, Sahu RN, Patnaik A.

Childs Nerv Syst. 2018 Apr;34(4):591-592. doi: 10.1007/s00381-018-3757-2. Epub 2018 Feb 19. No abstract available.

PMID:
29460061
34.

Neutrophils and anti-cancer immunity: a paradigm shift in cancer immunotherapy.

Sturey R, Patnaik A.

Oncoscience. 2017 Nov 28;4(11-12):164-165. doi: 10.18632/oncoscience.378. eCollection 2017 Nov. No abstract available.

35.

Development of Thrombotic Thrombocytopenic Purpura in Association With the Monoclonal Antibody, Golimumab, Used to Treat Rheumatoid Arthritis, in a Case With Literature Review.

Cepeda J, Liedke C, Patnaik A, Yao Q.

J Clin Rheumatol. 2018 Jun;24(4):229-231. doi: 10.1097/RHU.0000000000000684. No abstract available.

PMID:
29293116
36.

Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma.

Robert C, Ribas A, Hamid O, Daud A, Wolchok JD, Joshua AM, Hwu WJ, Weber JS, Gangadhar TC, Joseph RW, Dronca R, Patnaik A, Zarour H, Kefford R, Hersey P, Zhang J, Anderson J, Diede SJ, Ebbinghaus S, Hodi FS.

J Clin Oncol. 2018 Jun 10;36(17):1668-1674. doi: 10.1200/JCO.2017.75.6270. Epub 2017 Dec 28.

PMID:
29283791
37.

Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer.

Goldman JW, Rosen LS, Tolcher AW, Papadopoulos K, Beeram M, Shi P, Pitou C, Bell R, Kulanthaivel P, Zhang X, Fink A, Chan EM, Shahir A, Farrington D, Patnaik A.

Invest New Drugs. 2018 Aug;36(4):629-637. doi: 10.1007/s10637-017-0532-2. Epub 2017 Dec 1.

38.

All Fiber-Coupled OH Planar Laser-Induced-Fluorescence (OH-PLIF)-Based Two-Dimensional Thermometry.

Hsu PS, Jiang N, Patnaik AK, Katta V, Roy S, Gord JR.

Appl Spectrosc. 2018 Apr;72(4):604-610. doi: 10.1177/0003702817744519. Epub 2017 Nov 28.

PMID:
29148279
39.

FLEET velocimetry for combustion and flow diagnostics.

DeLuca NJ, Miles RB, Jiang N, Kulatilaka WD, Patnaik AK, Gord JR.

Appl Opt. 2017 Nov 1;56(31):8632-8638. doi: 10.1364/AO.56.008632.

PMID:
29091674
40.

A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours.

Papadopoulos KP, El-Rayes BF, Tolcher AW, Patnaik A, Rasco DW, Harvey RD, LoRusso PM, Sachdev JC, Abbadessa G, Savage RE, Hall T, Schwartz B, Wang Y, Kazakin J, Shaib WL.

Br J Cancer. 2017 Nov 21;117(11):1592-1599. doi: 10.1038/bjc.2017.330. Epub 2017 Oct 3.

41.

Extensive intracranial calcification of pseudo-TORCH syndrome with features of Dandy-Walker malformation.

Patnaik A, Mishra SS, Das S.

Asian J Neurosurg. 2017 Jul-Sep;12(3):541-543. doi: 10.4103/1793-5482.145162.

42.

Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors.

Tolcher AW, Sznol M, Hu-Lieskovan S, Papadopoulos KP, Patnaik A, Rasco DW, Di Gravio D, Huang B, Gambhire D, Chen Y, Thall AD, Pathan N, Schmidt EV, Chow LQM.

Clin Cancer Res. 2017 Sep 15;23(18):5349-5357. doi: 10.1158/1078-0432.CCR-17-1243. Epub 2017 Jun 20.

43.

Structure and Dynamics of a N-Methylfulleropyrrolidine-Mediated Gold Nanocomposite: A Spectroscopic Ruler.

Sutradhar S, Patnaik A.

ACS Appl Mater Interfaces. 2017 Jul 5;9(26):21921-21932. doi: 10.1021/acsami.7b02640. Epub 2017 Jun 20.

PMID:
28593769
44.

Biosynthesis, characterization and antibacterial activity of silver nanoparticles using an endophytic fungal supernatant of Raphanus sativus.

Singh T, Jyoti K, Patnaik A, Singh A, Chauhan R, Chandel SS.

J Genet Eng Biotechnol. 2017 Jun;15(1):31-39. doi: 10.1016/j.jgeb.2017.04.005. Epub 2017 Apr 22.

45.

Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC.

Piizzi G, Parker DT, Peng Y, Dobler M, Patnaik A, Wattanasin S, Liu E, Lenoir F, Nunez J, Kerrigan J, McKenney D, Osborne C, Yu D, Lanieri L, Bojkovic J, Dzink-Fox J, Lilly MD, Sprague ER, Lu Y, Wang H, Ranjitkar S, Xie L, Wang B, Glick M, Hamann LG, Tommasi R, Yang X, Dean CR.

J Med Chem. 2017 Jun 22;60(12):5002-5014. doi: 10.1021/acs.jmedchem.7b00377. Epub 2017 Jun 9.

PMID:
28549219
46.

Effect of Selected Yogic Practices on Pain and Disability in Patients with Lumbar Spondylitis.

Manik RK, Mahapatra AK, Gartia R, Bansal S, Patnaik A.

Int J Yoga. 2017 May-Aug;10(2):81-87. doi: 10.4103/0973-6131.205516.

47.

Infective Endocarditis of the Left Main to Right Atrial Coronary Cameral Fistula.

Mishra RC, Barik R, Patnaik AN.

J Cardiovasc Echogr. 2016 Oct-Dec;26(4):123-126. doi: 10.4103/2211-4122.192178.

48.

Intraventricular glioblastoma multiforme mimicking meningioma and review of the literature.

Patnaik A, Mishra SS, Senapati SB.

Asian J Neurosurg. 2017 Jan-Mar;12(1):75-77. doi: 10.4103/1793-5482.145104.

49.

Spontaneous extradural and subgaleal hematoma: A rare neurosurgical crisis of sickle cell disease.

Mishra SS, Senapati SB, Gouda AK, Behera SK, Patnaik A.

Asian J Neurosurg. 2017 Jan-Mar;12(1):47-50. doi: 10.4103/1793-5482.144177.

50.

Unusual Nonemissive Behavior of Rubrene J-Aggregates: A Rare Violation.

Aggarwal N, Patnaik A.

J Phys Chem B. 2017 Apr 13;121(14):3190-3201. doi: 10.1021/acs.jpcb.7b02072. Epub 2017 Mar 30.

PMID:
28334526

Supplemental Content

Loading ...
Support Center